Evidence map›Paper›PMID 42666222›Full record

ArticleFrontiers in immunology2026

Analysis of influencing factors for syphilis serofast and development and evaluation of a predictive model.

Jing Wen, Zhen Li, Wenchao Li, Danxuan Liu, Yongxiang Yu, Zhenzhen Wang, Gongqi Yu, Pengcheng Huai, Wen Sun, Qing Pan and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jing Wen *Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Zhen Li *Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Wenchao LiDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Danxuan LiuDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Yongxiang YuDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Zhenzhen WangDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Gongqi YuDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Pengcheng HuaiDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Wen SunDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Qing PanDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Chuan WangDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Hongqing TianDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Hong LiuDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Furen ZhangDermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the rising incidence of syphilis in recent decades, the number of patients with syphilis serofast has also increased, posing challenges to clinical management of patients and increasing the social burden. Objective: In this study, we aimed to analyze influencing factors associated with syphilis serofast, develop and validate a predictive model for clinical prevention of syphilis serofast. Methods: A total of 373 syphilis patients were selected as the study subjects. Using a multivariate logistic regression model to analyze the relevant influencing factors of syphilis serofast, and the receiver operating curve (ROC) was used to evaluate the predictive performance of relevant influencing factors for syphilis serofast. Additionally, 187 syphilis patients were selected to verify the performance of the aforementioned model. Results: Among the 373 syphilis patients, serofast occurred in 134 patients (35.92%). Multivariate logistic analysis indicated that syphilis stage (SS), baseline TRUST titer (BTT), and TRUST titer changes at three months post-treatment (TTC-3M) were closely associated with the occurrence of syphilis serofast. Further ROC curve analysis revealed that the combined prediction of serofast by these three factors yielded an area under the ROC curve of 0.87 (95% CI: 0.84-0.91, P < 0.001). Subsequently, the predictive performance of the aforementioned model was evaluated, achieving an actual sensitivity of 0.88 and a specificity of 0.81 in 187 syphilis patients. Conclusions: SS, BTT, and TTC-3M are key factors influencing the occurrence of syphilis serofast. The predictive model constructed based on these three factors exhibits good efficacy and possesses clinical application value.

Indexed as

SyphilisSyphilis SerodiagnosisTreponema pallidumAdultFemaleHumansMaleMiddle AgedROC Curveinfluencing factorspredictive modelserofastsyphilistoluidine red unheated serum test (TRUST)

Identifiers

PMID42666222
PMCPMC13521870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.